DUBLIN, Ohio--(BUSINESS WIRE)--Macrophage Therapeutics, Inc., a subsidiary of Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), today announced that a presentation of Manocept™ data from Kaposi’s sarcoma studies is scheduled at the American Association of Cancer Research (AACR) Annual Meeting 2015 in Philadelphia, PA from April 18 - 22, 2015. This research, led by Michael S. McGrath, M.D, Ph.D. and Toby Maurer, M.D., Kaposi’s sarcoma and HIV experts, at the University of California San Francisco, highlights both ex vivo and in vivo results in support of Manocept targeting of macrophages and tumor cells. Details of the presentation are listed below.
Help employers find you! Check out all the jobs and post your resume.
